Apoptosis-associated biomarkers in tuberculosis: Promising for diagnosis and prognosis prediction

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Shu, Chin Chung ^a,b   Wu, Ming Fang ^c   Hsu, Chia Lin ^a   Huang, Chun Ta ^a,b   Wang, Jann Yuan ^a   Hsieh, Shie Liang ^c   Yu, Chong Jen ^a   Lee, Li Na ^a   Yang, Pan Chyr ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Decoy receptor 3; Latent tuberculosis infection; Lipoxin; Prostaglandin E2; Tuberculosis

Indexed keywords

BIOLOGICAL MARKER; DECOY RECEPTOR 3; INTERLEUKIN 10; INTERLEUKIN 6; LIPOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; APOPTOSIS; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ACTIVITY; FAMILY; FEMALE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL TIME; TUBERCULOSIS;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HUMANS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; TUBERCULOSIS;

EID: 84872768526     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-45     Document Type: Article

References (31)

1. World Health Organization Global tuberculosis control: surveillance, planning, financing 2008, Geneva, Switzerland: World Health Organization, World Health Organization.
2. World Health Organization Group at risk: WHO report on the tuberculosis epidemic 1996, Geneva, Switzerland: World Health Organization, World Health Organization.
3. Chang FY, Shih WY, Lin T, Chou JH, Chen YH, Liu DP, Yang CH, Chen CH, Yen CC, Wu HS, Wu PF, Cheng AH, Ke YF, Tien CF, Wu YH. CDC annual report 2011 2011, Centers of Disease Control, Department of Health, R.O.C. (Taiwan), Taipei.
4. American Thoracic Society, CDC, and Infectious Diseases Society of America Treatment of tuberculosis. MMWR Recomm Rep 2003, 52(RR-11):1-77. American Thoracic Society, CDC, and Infectious Diseases Society of America.
5. Luh KT, Chiang CY, Lee JJ, Wang JY, Wang KF, Yu MC, Lee PI, Lee PH, Lin HH, Chiang IH, Chan PC, So R, Su WJ, Hung CC. Taiwan guidelines for TB diangosis and treatment 2011, Taiwan (R.O.C.): Center for Disease Control, Executive Yuan.
6. Hopewell PC, Kato-maeda M. Tuberculosis. Murray and Nadel's textbook of respiratory medicine. Volume 1 2010, 754-792. Elsevier Inc in Philadelphia, Pennsylvania, the United States of America, Mason RJ, Broaddus VC, Martin T, King T, Schraufnagel D, Murray JF, Nadel JA, 5.
7. Lundin AP, Adler AJ, Berlyne GM, Friedman EA. Tuberculosis in patients undergoing maintenance hemodialysis. Am J Med 1979, 67(4):597-602. 10.1016/0002-9343(79)90240-7, 495629.
8. Jick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 2006, 55(1):19-26. 10.1002/art.21705, 16463407.
9. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of bacille calmette guerin vaccination on tuberculin skin test measurements. Thorax 2002, 57(9):804-809. 10.1136/thorax.57.9.804, 1746436, 12200526.
10. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149(3):177-184. 2951987, 18593687.
11. Chang KC, Leung CC. Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios. Thorax 2010, 65(3):271-276. 10.1136/thx.2009.126771, 20335301.
12. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with mycobacterium tuberculosis. Am J Respir Crit Care Med 2008, 177(10):1164-1170. 10.1164/rccm.200711-1613OC, 18276940.
13. Jo EK. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs. Curr Opin Infect Dis 2008, 21(3):279-286. 10.1097/QCO.0b013e3282f88b5d, 18448973.
14. Noss EH, Pai RK, Sellati TJ, Radolf JD, Belisle J, Golenbock DT, Boom WH, Harding CV. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of mycobacterium tuberculosis. J Immunol 2001, 167(2):910-918.
15. Chen M, Gan H, Remold HG. A mechanism of virulence: virulent mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J Immunol 2006, 176(6):3707-3716.
16. Jung SB, Yang CS, Lee JS, Shin AR, Jung SS, Son JW, Harding CV, Kim HJ, Park JK, Paik TH, et al. The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through toll-like receptors 2 and 4 in human monocytes. Infect Immun 2006, 74(5):2686-2696. 10.1128/IAI.74.5.2686-2696.2006, 1459749, 16622205.
17. Torrado E, Robinson RT, Cooper AM. Cellular response to mycobacteria: balancing protection and pathology. Trends Immunol 2011, 32(2):66-72. 10.1016/j.it.2010.12.001, 3039081, 21216195.
18. Blomgran R, Desvignes L, Briken V, Ernst JD. Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells. Cell Host Microbe 2012, 11(1):81-90. 10.1016/j.chom.2011.11.012, 3266554, 22264515.
19. Lin WW, Hsieh SL. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer. Biochem Pharmacol 2011, 81(7):838-847. 10.1016/j.bcp.2011.01.011, 21295012.
20. Bafica A, Scanga CA, Serhan C, Machado F, White S, Sher A, Aliberti J. Host control of mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. J Clin Invest 2005, 115(6):1601-1606. 10.1172/JCI23949, 1136995, 15931391.
21. Harries A. What is the additional yield from repeated sputum examinations by microscopy and culture?. Toman's Tuberculosis case detection, treatment and monitoring 2004, 46-50. Geneva: World Health Organization, Frieden TR.
22. Gauglitz GG, Finnerty CC, Herndon DN, Mlcak RP, Jeschke MG. Are serum cytokines early predictors for the outcome of burn patients with inhalation injuries who do not survive?. Crit Care 2008, 12(3):R81. 10.1186/cc6932, 2481480, 18564432.
23. Shu CC, Wang JT, Wang JY, Lee LN, Yu CJ. In-hospital outcome of patients with culture-confirmed tuberculous pleurisy: clinical impact of pulmonary involvement. BMC Infect Dis 2011, 11:46. 10.1186/1471-2334-11-46, 3051910, 21338482.
24. Shu CC, Lee LN, Wu MF, Lee CH, Wang JT, Wang JY, Yu CJ. Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease. Int J Tuberc Lung Dis 2011, 15(10):1415-1420. 10.5588/ijtld.10.0786, 22283904.
25. Arcila ML, Sanchez MD, Ortiz B, Barrera LF, Garcia LF, Rojas M. Activation of apoptosis, but not necrosis, during mycobacterium tuberculosis infection correlated with decreased bacterial growth: role of TNF-alpha, IL-10, caspases and phospholipase A2. Cell Immunol 2007, 249(2):80-93. 10.1016/j.cellimm.2007.11.006, 18160064.
26. Park JS, Tamayo MH, Gonzalez-Juarrero M, Orme IM, Ordway DJ. Virulent clinical isolates of mycobacterium tuberculosis grow rapidly and induce cellular necrosis but minimal apoptosis in murine macrophages. J Leukoc Biol 2006, 79(1):80-86.
27. Chen M, Divangahi M, Gan H, Shin DS, Hong S, Lee DM, Serhan CN, Behar SM, Remold HG. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med 2008, 205(12):2791-2801. 10.1084/jem.20080767, 2585850, 18955568.
28. You RI, Chang YC, Chen PM, Wang WS, Hsu TL, Yang CY, Lee CT, Hsieh SL. Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3). Blood 2008, 111(3):1480-1488.
29. Flores-Villanueva PO, Ruiz-Morales JA, Song CH, Flores LM, Jo EK, Montano M, Barnes PF, Selman M, Granados J. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med 2005, 202(12):1649-1658. 10.1084/jem.20050126, 2212957, 16352737.
30. Chang YC, Chen TC, Lee CT, Yang CY, Wang HW, Wang CC, Hsieh SL. Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3. Blood 2008, 111(10):5054-5063. 10.1182/blood-2007-12-130609, 18349319.
31. Premack BA, Schall TJ. Chemokine receptors: gateways to inflammation and infection. Nat Med 1996, 2(11):1174-1178. 10.1038/nm1196-1174, 8898734.